USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/19654
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGrosul, Iea-
dc.date.accessioned2022-01-26T10:11:11Z-
dc.date.available2022-01-26T10:11:11Z-
dc.date.issued2012-
dc.identifier.citationGROSUL, Iea. Association between statin therapy and in stent restenosis. In: MedEspera: the 4th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2012, p. 91.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/19654-
dc.description.abstractIntroduction: Restenosis after percutaneous coronary interventions (PCI) remains an unsolved clinical problem. Increasing evidence indicates the importance of inflammatory responses to vascular injury in the pathogenesis of restenosis. Several agents with anti-inflammatory action have been studied for the prevention of restenosis post-PCI, including statins. Their pleiotropic effects act favorably on disease progression. The aim of our retrospective study was to examine the association between statin therapy and occurrence of instent restenosis. Methods: A total of 67 patients (mean age of 56 years, range 39-72 years, 82% men, 24% with diabetes mellitus) with coronary stents who underwent a repeated coronary angiography due to worsening of their clinical symptoms, were enrolled in the study. According to angiographic findings these patients were divided into three groups: 1st group - without instent restenosis and progression of other coronary lesions (15 patients); 2nd group - patients with instent restenosis ± progression of other coronary lesions (28 patients) and 3rd group - without instent restenosis, but with progression of other coronary lesions (24 patients). Results: 47 (70%) patients were on treatment with statins and 20 (30%) patients did not receive any statins after initial PCI. The number of patients that did not receive statins in each of these three groups were the following: in 1st group - 2 (13,3%) patients; 2nd group - 10 (35,7%) patients and 3rd group - 8 (33,3%) patients-. The high percentage of patients that were not receiving statins is explained by low medication compliance. In addition, there were no differences in total cholesterol (CT), LDL-choloesterol (LDL-C) and HDL-cholesterol (HDL-C) levels between these three groups, irrespective of statins treatment: 1st group - CT - 5,02 mmol/1, HDL-C - 1,23 mmol/1, LDL-C - 2,93 mmol/1; 2nd group - CT - 4,97 mmol/1, HDL-C - 1,2 mmol/1, LDL-C - 2,88 mmol/1 and 3rd group - CT - 4,9 mmol/1, HDL-C - 1,21 mmol/1, LDL-C - 2,83 mmol/1. Conclusion: This study suggests that statins may have a favorable effect in reducing the angiographic restenosis independent of their cholesterol-lowering effect. Statin therapy improve clinical outcome of patients after percutaneous coronary interventions and represents an independent predictor factor for restenosis.en_US
dc.language.isoenen_US
dc.publisherState Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association, Scientific Association of Students and Young Doctorsen_US
dc.relation.ispartofMedEspera: The 4th International Medical Congress for Students and Young Doctors, May 17-19, 2012, Chisinau, Republic of Moldovaen_US
dc.subjectpercutaneous coronary interventionen_US
dc.subjectinstent restenosisen_US
dc.subjectstatinsen_US
dc.titleAssociation between statin therapy and in stent restenosisen_US
dc.typeOtheren_US
Appears in Collections:MedEspera 2012

Files in This Item:
File Description SizeFormat 
ASSOCIATION_BETWEEN_STATIN_THERAPY_A_N_D_IN_STENT_RESTENOSIS.pdf50.55 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback